<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39388147</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-751X</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of cardiopulmonary rehabilitation and prevention</Title><ISOAbbreviation>J Cardiopulm Rehabil Prev</ISOAbbreviation></Journal><ArticleTitle>Pulmonary Rehabilitation for Diseases Other Than COPD.</ArticleTitle><Pagination><StartPage>425</StartPage><EndPage>431</EndPage><MedlinePgn>425-431</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/HCR.0000000000000915</ELocationID><Abstract><AbstractText>Review the current literature regarding pulmonary rehabilitation (PR) for non-chronic obstructive pulmonary disease (COPD) diagnoses and what the evidence is regarding expected outcomes based on disease manifestations. Literature search was performed using PubMed database from March 2024 to June 2024. Terms included "pulmonary rehabilitation" and "exercise training" in conjunction with key words "interstitial lung disease (ILD)," "idiopathic pulmonary fibrosis," "asthma," "bronchiectasis," "post-acute sequalae of SARS-CoV-2 (PASC)," "long COVID," "pulmonary hypertension (PH)," and "lung cancer." Results were filtered for English language, randomized controlled trial, clinical trial, observational trial, meta-analysis, and guidelines. Emphasis was placed on more recent publications since prior reviews, where applicable. The abundance of literature involved ILD, where studies have demonstrated significant improvements in exercise capacity, health-related quality of life (HRQoL), and dyspnea, despite heterogeneity of diseases; benefits are similar to those seen with COPD. Those with milder disease have more sustained benefits longer term. Patients with asthma benefit in severe disease, lower exercise activity, elevated body mass index, or when comorbid conditions are present, and breathing exercises can improve symptoms of breathlessness. Patients with PASC have a multitude of symptoms and lack benefits in HRQoL measurements; PR improves performance on post-COVID-19 functional status scale, a more comprehensive measurement of symptoms. Those with bronchiectasis benefit from PR when airflow limitation or exacerbations are impacting symptoms and HRQoL. Those with stable PH can improve their exertional capacity without change in disease severity. PR reduces perioperative complications in those with lung cancer and preserve fitness during treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Menson</LastName><ForeName>Katherine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Author Affiliations: Division of Pulmonary and Critical Care Medicine, University of Vermont, Burlington, Vermont (Dr Menson); and Respiratory Care Group, Monash University, Melbourne, Victoria, Australia (Dr Dowman).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dowman</LastName><ForeName>Leona</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiopulm Rehabil Prev</MedlineTA><NlmUniqueID>101291247</NlmUniqueID><ISSNLinking>1932-7501</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017079" MajorTopicYN="N">Exercise Tolerance</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="N">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001987" MajorTopicYN="N">Bronchiectasis</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest: All authors declare no conflicts of interest. Katherine Menson has research support from the NIH and American Lung Association.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>1</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>13</Day><Hour>21</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39388147</ArticleId><ArticleId IdType="doi">10.1097/HCR.0000000000000915</ArticleId><ArticleId IdType="pii">01273116-990000000-00180</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-e64. doi:10.1164/rccm.201309-1634ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201309-1634ST</ArticleId></ArticleIdList></Reference><Reference><Citation>Casaburi R. A brief history of pulmonary rehabilitation. Respir Care. 2008;53(9):1185-1189.</Citation></Reference><Reference><Citation>Ferreira G, Feuerman M, Spiegler P. Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2006;26(1):54-60. doi:10.1097/00008483-200601000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008483-200601000-00011</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochester CL, Alison JA, Carlin B, et al. Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2023;208(4):e7-e26. doi:10.1164/rccm.202306-1066ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202306-1066ST</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochester CL, Fairburn C, Crouch RH. Pulmonary rehabilitation for respiratory disorders other than chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(2):369-389. doi:10.1016/j.ccm.2014.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2014.02.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Granger CL, Morris NR, Holland AE. Practical approach to establishing pulmonary rehabilitation for people with non-COPD diagnoses. Respirology. 2019;24(9):879-888. doi:10.1111/resp.13562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.13562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijsenbeek MS, Holland AE, Swigris JJ, Renzoni EA. Comprehensive supportive care for patients with fibrosing interstitial lung disease. Am J Respir Crit Care Med. 2019;200(2):152-159. doi:10.1164/rccm.201903-0614PP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201903-0614PP</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman M, Mellerick C, Symons K, Glaspole I, Holland AE. Pulmonary rehabilitation for interstitial lung disease: referral and patient experiences. Chron Respir Dis. 2021;18:14799731211046022. doi:10.1177/14799731211046022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211046022</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowman L, Hill CJ, May A, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2021;2(2):CD006322. doi:10.1002/14651858.CD006322.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006322.pub4</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowman LM, McDonald CF, Hill CJ, et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax. 2017;72(7):610-619. doi:10.1136/thoraxjnl-2016-208638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2016-208638</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunetti G, Malovini A, Maniscalco M, et al. Pulmonary rehabilitation in patients with interstitial lung diseases: correlates of success. Respir Med. 2021;185:106473. doi:10.1016/j.rmed.2021.106473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106473</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Bogerd S, Wuyts W, Barbier V, et al. Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial. Respir Res. 2018;19(1):182. doi:10.1186/s12931-018-0884-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-018-0884-y</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2015(2):CD003793. doi:10.1002/14651858.CD003793.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003793.pub3</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan CM, Polgar O, Schofield SJ, et al. Pulmonary rehabilitation in idiopathic pulmonary fibrosis and copd: a propensity-matched real-world study. Chest. 2022;161(3):728-737. doi:10.1016/j.chest.2021.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.10.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Hur SA, Stickland MK, et al. Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study. Thorax. 2022;77(6):589-595. doi:10.1136/thoraxjnl-2021-217361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217361</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18-e47. doi:10.1164/rccm.202202-0399ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202202-0399ST</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackintosh JA, Keir G, Troy LK, et al. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: a position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 2024;29(2):105-135. doi:10.1111/resp.14656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14656</ArticleId></ArticleIdList></Reference><Reference><Citation>Jee AS, Sheehy R, Hopkins P, et al. Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2021;26(1):23-51. doi:10.1111/resp.13977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.13977</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma S, Bando M, Azuma A, et al. Japanese guideline for the treatment of idiopathic pulmonary fibrosis. Respir Investig. 2018;56(4):268-291. doi:10.1016/j.resinv.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2018.03.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton CE, Bevan-Smith EF, Blakey JD, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68(Suppl 2):ii1-30. doi:10.1136/thoraxjnl-2013-203808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2013-203808</ArticleId></ArticleIdList></Reference><Reference><Citation>Osadnik CR, Gleeson C, McDonald VM, Holland AE. Pulmonary rehabilitation versus usual care for adults with asthma. Cochrane Database Syst Rev. 2022;8(8):CD013485. doi:10.1002/14651858.CD013485.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013485.pub2</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. www.ginaasthma.org . Accessed May 18, 2024.</Citation></Reference><Reference><Citation>McCracken JL, Veeranki SP, Ameredes BT, Calhoun WJ. Diagnosis and management of asthma in adults: a review. JAMA. 2017;318(3):279-290. doi:10.1001/jama.2017.8372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.8372</ArticleId></ArticleIdList></Reference><Reference><Citation>Satar S, Sahin ME, Ergun P. Factors affecting the success of pulmonary rehabilitation in asthma. J Asthma. 2023;60(5):912-919. doi:10.1080/02770903.2022.2109163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2022.2109163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampogna E, Paneroni M, Cherubino F, et al. Effectiveness of a pulmonary rehabilitation program on persistent asthma stratified for severity. Respir Care. 2019;64(12):1523-1530. doi:10.4187/respcare.06761.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.06761</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampogna E, Centis R, Negri S, et al. Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis. J Asthma. 2020;57(12):1365-1371. doi:10.1080/02770903.2019.1646271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2019.1646271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricketts HC, Sharma V, Steffensen F, et al. A pragmatic randomised controlled trial of tailored pulmonary rehabilitation in participants with difficult-to-control asthma and elevated body mass index. BMC Pulm Med. 2022;22(1):363. doi:10.1186/s12890-022-02152-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-022-02152-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosbois JM, Coquart J, Fry S, et al. Long-term effect of home-based pulmonary rehabilitation in severe asthma. Respir Med. 2019;157:36-41. doi:10.1016/j.rmed.2019.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2019.08.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Evaristo KB, Mendes FAR, Saccomani MG, et al. Effects of aerobic training versus breathing exercises on asthma control: a randomized trial. J Allergy Clin Immunol Pract. 2020;8(9):2989-2996e4. doi:10.1016/j.jaip.2020.06.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2020.06.042</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329(22):1934-1946. doi:10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, et al. Global Burden of Disease Long CC. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604-1615. doi:10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo BTS, Barros A, Nunes DTX, et al. Effects of continuous aerobic training associated with resistance training on maximal and submaximal exercise tolerance, fatigue, and quality of life of patients post-COVID-19. Physiother Res Int. 2023;28(1):e1972. doi:10.1002/pri.1972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pri.1972</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugazzaro S, Contri A, Esseroukh O, et al. Rehabilitation interventions for post-acute COVID-19 syndrome: a systematic review. Int J Environ Res Public Health. 2022;19(9):5185. doi:10.3390/ijerph19095185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095185</ArticleId></ArticleIdList></Reference><Reference><Citation>Melendez-Oliva E, Martinez-Pozas O, Cuenca-Zaldivar JN, Villafane JH, Jimenez-Ortega L, Sanchez-Romero EA. Efficacy of pulmonary rehabilitation in post-COVID-19: a systematic review and meta-analysis. Biomedicines. 2023;11(8):2213. doi:10.3390/biomedicines11082213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11082213</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok FA, et al. Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. 2022;101(6):593-601. doi:10.1159/000522118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R, Leitl D, Jarosch I, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021;7(2):00108-2021. doi:10.1183/23120541.00108-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00108-2021</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallier JM, Simon C, Bronstein A, et al. Randomized controlled trial of home-based vs. hospital-based pulmonary rehabilitation in post COVID-19 patients. Eur J Phys Rehabil Med. 2023;59(1):103-110. doi:10.23736/S1973-9087.22.07702-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.22.07702-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Pozas O, Melendez-Oliva E, Rolando LM, Rico JAQ, Corbellini C, Sanchez Romero EA. The pulmonary rehabilitation effect on long covid-19 syndrome: a systematic review and meta-analysis. Physiother Res Int. 2024;29(2):e2077. doi:10.1002/pri.2077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pri.2077</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AL, Gordon CS, Osadnik CR. Exercise training for bronchiectasis. Cochrane Database Syst Rev. 2021;4(4):CD013110. doi:10.1002/14651858.CD013110.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013110.pub2</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-Yoseph R, Ilivitzki A, Cooper DM, et al. Exercise capacity in patients with cystic fibrosis vs. non-cystic fibrosis bronchiectasis. PLoS One. 2019;14(6):e0217491. doi:10.1371/journal.pone.0217491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0217491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ora J, Prendi E, Ritondo BL, Pata X, Spada F, Rogliani P. Pulmonary rehabilitation in noncystic fibrosis bronchiectasis. Respiration. 2022;101(1):97-105. doi:10.1159/000517527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000517527</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S, Cole AD, Nolan CM, et al. Pulmonary rehabilitation in bronchiectasis: a propensity-matched study. Eur Respir J. 2019;53(1):1801264. doi:10.1183/13993003.01264-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01264-2018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini A, Aiello M, Adamo D, et al. Effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a retrospective analysis of clinical and functional predictors of efficacy. Respiration. 2015;89(6):525-533. doi:10.1159/000380771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000380771</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz KD, Walsh A, Southern KW, Johnstone Z, Regan KH. Exercise versus airway clearance techniques for people with cystic fibrosis. Cochrane Database Syst Rev. 2022;6(6):CD013285. doi:10.1002/14651858.CD013285.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013285.pub2</ArticleId></ArticleIdList></Reference><Reference><Citation>Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629. doi:10.1183/13993003.00629-2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00629-2017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AT, Welham SA, Sullivan AL, Loebinger MR. Updated BTS adult bronchiectasis guideline 2018: a multidisciplinary approach to comprehensive care. Thorax. 2019;74(1):1-3. doi:10.1136/thoraxjnl-2018-212468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2018-212468</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AL, Hill CJ, Cecins N, et al. The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis&#x2014;a randomised controlled trial. Respir Res. 2014;15(1):44. doi:10.1186/1465-9921-15-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-15-44</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo AS, Figueiredo MR, Lomonaco I, Lundgren F, Mesquita R, Pereira EDB. Effects of pulmonary rehabilitation on systemic inflammation and exercise capacity in bronchiectasis: a randomized controlled trial. Lung. 2022;200(3):409-417. doi:10.1007/s00408-022-00540-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-022-00540-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Gao L, Wang Q, Deng W, Gao W. Effect of exercise-based pulmonary rehabilitation in patients with bronchiectasis: a meta-analysis. Respir Med Res. 2022;81:100910. doi:10.1016/j.resmer.2022.100910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resmer.2022.100910</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal P, Sidhu MK, Kope L, et al. A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis. Respir Med. 2012;106(12):1647-1654. doi:10.1016/j.rmed.2012.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2012.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose A, Holland AE, Selman JPR, et al. Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial. ERJ Open Res. 2021;7(2):00021-2021. doi:10.1183/23120541.00021-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00021-2021</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris NR, Kermeen FD, Holland AE. Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database Syst Rev. 2017;1(1):CD011285. doi:10.1002/14651858.CD011285.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011285.pub2</ArticleId></ArticleIdList></Reference><Reference><Citation>Humbert M, Kovacs G, Hoeper MM, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618-3731. doi:10.1093/eurheartj/ehac237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac237</ArticleId></ArticleIdList></Reference><Reference><Citation>Galie N, Humbert M, Vachiery JL, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67-119. doi:10.1093/eurheartj/ehv317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv317</ArticleId></ArticleIdList></Reference><Reference><Citation>Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2023;61(1):2200879. doi:10.1183/13993003.00879-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00879-2022</ArticleId></ArticleIdList></Reference><Reference><Citation>Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006;114(14):1482-1489. doi:10.1161/CIRCULATIONAHA.106.618397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.618397</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris NR, Kermeen FD, Jones AW, Lee JY, Holland AE. Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database Syst Rev. 2023;3(3):CD011285. doi:10.1002/14651858.CD011285.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011285.pub3</ArticleId></ArticleIdList></Reference><Reference><Citation>An QY, Wang L, Yuan P, et al. Effectiveness and safety of exercise training and rehabilitation in chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(7):8134-8146. doi:10.21037/apm-21-1758.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-21-1758</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunig E, MacKenzie A, Peacock AJ, et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. Eur Heart J. 2021;42(23):2284-2295. doi:10.1093/eurheartj/ehaa696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa696</ArticleId></ArticleIdList></Reference><Reference><Citation>de Man FS, Handoko ML, Groepenhoff H, et al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2009;34(3):669-675. doi:10.1183/09031936.00027909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00027909</ArticleId></ArticleIdList></Reference><Reference><Citation>Group USCSW. U.S. Cancer Statistics Data Visualizations Tool, based on 2021 submission data (1999-2019). U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Updated November 2022. https://www.cdc.gov/cancer/dataviz . Accessed April 26, 2024.</Citation></Reference><Reference><Citation>Komici K, Bencivenga L, Navani N, et al. Frailty in patients with lung cancer: a systematic review and meta-analysis. Chest. 2022;162(2):485-497. doi:10.1016/j.chest.2022.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.02.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chen YF, Wu WT, et al. Impact of sarcopenia on the prognosis and treatment of lung cancer: an umbrella review. Discov Oncol. 2022;13(1):115. doi:10.1007/s12672-022-00576-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12672-022-00576-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Anraku M, Kawahara T, et al. Combination of skeletal muscle mass and density predicts postoperative complications and survival of patients with non-small cell lung cancer. Ann Surg Oncol. 2022;29(3):1816-1824. doi:10.1245/s10434-021-11024-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-021-11024-8</ArticleId></ArticleIdList></Reference><Reference><Citation>National Lung Screening Trial, Research T, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409. doi:10.1056/NEJMoa1102873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1102873</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Wang H, Jiang Y, et al. Advances in lung cancer screening and early detection. Cancer Biol Med. 2022;19(5):591-608. doi:10.20892/j.issn.2095-3941.2021.0690.</Citation><ArticleIdList><ArticleId IdType="doi">10.20892/j.issn.2095-3941.2021.0690</ArticleId></ArticleIdList></Reference><Reference><Citation>Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380-386. doi:10.1183/09031936.00144208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00144208</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalheri V, Granger CL. Exercise training as part of lung cancer therapy. Respirology. 2020;25 Suppl 2(S2):80-87. doi:10.1111/resp.13869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.13869</ArticleId></ArticleIdList></Reference><Reference><Citation>Granger C, Cavalheri V. Preoperative exercise training for people with non-small cell lung cancer. Cochrane Database Syst Rev. 2022;9(9):CD012020. doi:10.1002/14651858.CD012020.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD012020.pub3</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzo R, Wigle D, Novotny P, et al. Preoperative pulmonary rehabilitation before lung cancer resection: results from two randomized studies. Lung Cancer. 2011;74(3):441-445. doi:10.1016/j.lungcan.2011.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lungcan.2011.05.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobbio A, Chetta A, Ampollini L, et al. Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg. 2008;33(1):95-98. doi:10.1016/j.ejcts.2007.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2007.10.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Messaggi-Sartor M, Marco E, Martinez-Tellez E, et al. Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial. Eur J Phys Rehabil Med. 2019;55(1):113-122. doi:10.23736/S1973-9087.18.05156-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.18.05156-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, Sun C. Effect of physical manipulation pulmonary rehabilitation on lung cancer patients after thoracoscopic lobectomy. Thorac Cancer. 2022;13(3):308-315. doi:10.1111/1759-7714.14225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1759-7714.14225</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalheri V, Burtin C, Formico VR, et al. Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. Cochrane Database Syst Rev. 2019;6(6):CD009955. doi:10.1002/14651858.CD009955.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009955.pub3</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito T, Mitsunaga S, Miura S, et al. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle. 2019;10(1):73-83. doi:10.1002/jcsm.12351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12351</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkowska A, Jastrzebski D, Rutkowski S, et al. Exercise training in patients with non-small cell lung cancer during in-hospital chemotherapy treatment: a randomized controlled trial. J Cardiopulm Rehabil Prev. 2019;39(2):127-133. doi:10.1097/HCR.0000000000000410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCR.0000000000000410</ArticleId></ArticleIdList></Reference><Reference><Citation>Glattki GP, Manika K, Sichletidis L, Alexe G, Brenke R, Spyratos D. Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment. Am J Clin Oncol. 2012;35(2):120-125. doi:10.1097/COC.0b013e318209ced7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COC.0b013e318209ced7</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott JM, Thomas SM, Herndon JE, et al. Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial. J Cachexia Sarcopenia Muscle. 2021;12(6):1456-1465. doi:10.1002/jcsm.12828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12828</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenauer PK, Stefan MS, Pekow PS, et al. Association between initiation of pulmonary rehabilitation after hospitalization for COPD and 1-year survival among medicare beneficiaries. JAMA. 2020;323(18):1813-1823. doi:10.1001/jama.2020.4437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4437</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan MS, Pekow PS, Priya A, et al. Association between initiation of pulmonary rehabilitation and rehospitalizations in patients hospitalized with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;204(9):1015-1023. doi:10.1164/rccm.202012-4389OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202012-4389OC</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>